|
|
|
Volumn 26, Issue 5 SUPPL. 14, 1999, Pages 88-96
|
|
CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
PROTEIN BCL 2;
RITUXIMAB;
VINCRISTINE;
ADULT;
ADVERSE DRUG REACTION;
AGED;
ARTICLE;
B CELL LYMPHOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
REMISSION;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PREDNISOLONE;
REMISSION INDUCTION;
VINCRISTINE;
|
|
EID: 0032743141
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (103)
|
|
References (60)
|
